VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q41954405 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000201.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q41954405‏
024 ‎‡a 0000-0003-1670-2296‏ ‎‡2 orcid‏
024 ‎‡a 55317043700‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q41954405‏
100 0 ‎‡a Franz E Weber‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Franz E Weber‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Franz E Weber‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A comparative study of sterol absorption in different small-intestinal brush border membrane models‏
670 ‎‡a Author's A model system of the dynamic loading occurring in synovial joints: the biological effect of plowing on pristine cartilage‏
670 ‎‡a Author's A novel, tissue occlusive poly(ethylene glycol) hydrogel material‏
670 ‎‡a Author's A randomized controlled clinical multicenter trial comparing the clinical and histological performance of a new, modified polylactide-co-glycolide acid membrane to an expanded polytetrafluorethylene membrane in guided bone regeneration procedures‏
670 ‎‡a Author's A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2‏
670 ‎‡a Author's Absorption of monoacylglycerols by small intestinal brush border membrane‏
670 ‎‡a Author's Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2.‏
670 ‎‡a Author's Automatic registration of 2D histological sections to 3D microCT volumes: Trabecular bone‏
670 ‎‡a Author's Biodegradation and tissue integration of various polyethylene glycol matrices: a comparative study in rabbits.‏
670 ‎‡a Author's Biodegradation, soft and hard tissue integration of various polyethylene glycol hydrogels: a histomorphometric study in rabbits.‏
670 ‎‡a Author's Biomimetic Conditioning of Human Dentin Using Citric Acid‏
670 ‎‡a Author's Biomimetic PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides‏
670 ‎‡a Author's Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions‏
670 ‎‡a Author's BMP-2 and BMP-2/7 Heterodimers Conjugated to a Fibrin/Hyaluronic Acid Hydrogel in a Large Animal Model of Mild Intervertebral Disc Degeneration.‏
670 ‎‡a Author's Bone augmentation using a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute materials with and without recombinant human bone morphogenetic protein-2‏
670 ‎‡a Author's Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices‏
670 ‎‡a Author's Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate‏
670 ‎‡a Author's Bone regeneration by the osteoconductivity of porous titanium implants manufactured by selective laser melting: a histological and micro computed tomography study in the rabbit.‏
670 ‎‡a Author's Bone regeneration in the presence of a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute material‏
670 ‎‡a Author's Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material‏
670 ‎‡a Author's Bone regeneration using a synthetic matrix containing enamel matrix derivate‏
670 ‎‡a Author's Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices.‏
670 ‎‡a Author's [Bone substitutes]‏
670 ‎‡a Author's cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms.‏
670 ‎‡a Author's cDNA cloning and sequence comparisons of human and chicken muscle C-protein and 86kD protein‏
670 ‎‡a Author's Cell-Free translation of Balbiani ring RNA (75S) ofChironomus tentans salivary glands into high molecular weight products‏
670 ‎‡a Author's Cerium Chloride Application Promotes Wound Healing and Cell Proliferation in Human Foreskin Fibroblasts.‏
670 ‎‡a Author's Changes in free and bound forms and total amount of hexokinase isozyme II of rat muscle in response to contractile activity‏
670 ‎‡a Author's Characterization of lipid exchange proteins isolated from small intestinal brush border membrane‏
670 ‎‡a Author's Cholesteryl ester absorption by small intestinal brush border membrane is protein-mediated‏
670 ‎‡a Author's Comparative study of NMP-preloaded and dip-loaded membranes for guided bone regeneration of rabbit cranial defects‏
670 ‎‡a Author's Comparison of cholesterol and sitosterol uptake in different brush border membrane models‏
670 ‎‡a Author's Comparison of two resorbable membrane systems in bone regeneration after removal of wisdom teeth: a randomized-controlled clinical pilot study‏
670 ‎‡a Author's Contractile activity enhances the synthesis of hexokinase II in rat skeletal muscle‏
670 ‎‡a Author's Coupling plowing of cartilage explants with gene expression in models for synovial joints.‏
670 ‎‡a Author's Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.‏
670 ‎‡a Author's Delivery of BMP-2 by two clinically available apatite materials: in vitro and in vivo comparison‏
670 ‎‡a Author's Design, construction and validation of a computer controlled system for functional loading of soft tissue‏
670 ‎‡a Author's Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias.‏
670 ‎‡a Author's Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification.‏
670 ‎‡a Author's Effect of cerium chloride application on fibroblast and osteoblast proliferation and differentiation.‏
670 ‎‡a Author's Effect of different rhBMP-2 and TG-VEGF ratios on the formation of heterotopic bone and neovessels.‏
670 ‎‡a Author's Effect of direct current on surface structure and cytocompatibility of titanium dental implants‏
670 ‎‡a Author's Effect of platelet-derived growth factor-BB on tissue integration of cross-linked and non-cross-linked collagen matrices in a rat ectopic model.‏
670 ‎‡a Author's Effect of rhBMP-2 on guided bone regeneration in humans.‏
670 ‎‡a Author's Effect of short-time povidone-iodine application on osteoblast proliferation and differentiation.‏
670 ‎‡a Author's Effects of Stem Cell Factor on Cell Homing During Functional Pulp Regeneration in Human Immature Teeth‏
670 ‎‡a Author's Effects of μCT radiation on tissue engineered bone-like constructs.‏
670 ‎‡a Author's Elucidating the role of matrix stiffness in 3D cell migration and remodeling.‏
670 ‎‡a Author's Engineering 3D cell instructive microenvironments by rational assembly of artificial extracellular matrices and cell patterning‏
670 ‎‡a Author's Enhanced osteoblastic activity and bone regeneration using surface-modified porous bioactive glass scaffolds‏
670 ‎‡a Author's Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats‏
670 ‎‡a Author's Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering.‏
670 ‎‡a Author's Enzyme mediated site-specific surface modification.‏
670 ‎‡a Author's Epigenetic drugs as new therapy for tumor necrosis factor-α-compromised bone healing‏
670 ‎‡a Author's Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis‏
670 ‎‡a Author's Erratum: Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering‏
670 ‎‡a Author's Evaluation of an in situ formed synthetic hydrogel as a biodegradable membrane for guided bone regeneration‏
670 ‎‡a Author's Evaluation of moldable, in situ hardening calcium phosphate bone graft substitutes‏
670 ‎‡a Author's Fibrin gel improves tissue ingrowth and cell differentiation in human immature premolars implanted in rats.‏
670 ‎‡a Author's Fibrin Hydrogel Based Bone Substitute Tethered with BMP-2 and BMP-2/7 Heterodimers‏
670 ‎‡a Author's Functionalization of Ceramic Scaffolds with Exosomes from Bone Marrow Mesenchymal Stromal Cells for Bone Tissue Engineering‏
670 ‎‡a Author's Guided bone regeneration with a synthetic biodegradable membrane: a comparative study in dogs‏
670 ‎‡a Author's Heterodimeric BMP-2/7 for nucleus pulposus regeneration-In vitro and ex vivo studies.‏
670 ‎‡a Author's Heterotopic bone formation around vessels: pilot study of a new animal model‏
670 ‎‡a Author's High power-pulsed Nd:YAG laser as a new stimulus to induce BMP-2 expression in MC3T3-E1 osteoblasts‏
670 ‎‡a Author's Human myosin-binding protein H (MyBP-H): complete primary sequence, genomic organization, and chromosomal localization‏
670 ‎‡a Author's Identification of a receptor mediating absorption of dietary cholesterol in the intestine‏
670 ‎‡a Author's Immobilization of chondroitin sulfate to lipid membranes and its interactions with ECM proteins‏
670 ‎‡a Author's Impact of recombinant platelet-derived growth factor BB on bone regeneration: a study in rabbits.‏
670 ‎‡a Author's In pre-sterol carrier protein 2 (SCP2) in solution the leader peptide 1-20 is flexibly disordered, and residues 21-143 adopt the same globular fold as in mature SCP2‏
670 ‎‡a Author's In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation‏
670 ‎‡a Author's In vivo and in vitro evaluation of flexible, cottonwool-like nanocomposites as bone substitute material for complex defects‏
670 ‎‡a Author's Influence of N-methyl pyrrolidone on the activity of the pulp-dentine complex and bone integrity during osteoporosis‏
670 ‎‡a Author's Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone‏
670 ‎‡a Author's Intraoperative engineering of osteogenic grafts combining freshly harvested, human adipose-derived cells and physiological doses of bone morphogenetic protein-2‏
670 ‎‡a Author's Introduction of the Anspach drill as a novel surgical driller for creating calvarial defects in animal models‏
670 ‎‡a Author's Iodixanol as a Contrast Agent in a Fibrin Hydrogel for Endodontic Applications.‏
670 ‎‡a Author's Lattice Microarchitecture for Bone Tissue Engineering from Calcium Phosphate Compared to Titanium‏
670 ‎‡a Author's Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering‏
670 ‎‡a Author's Mechanical loading of mouse caudal vertebrae increases trabecular and cortical bone mass-dependence on dose and genotype.‏
670 ‎‡a Author's Microporosities in 3D-Printed Tricalcium-Phosphate-Based Bone Substitutes Enhance Osteoconduction and Affect Osteoclastic Resorption‏
670 ‎‡a Author's Molecular cloning of a peroxisomal Ca 2+ -dependent member of the mitochondrial carrier superfamily‏
670 ‎‡a Author's Molecular cloning of a peroxisomal Ca2+-dependent member of the mitochondrial carrier superfamily‏
670 ‎‡a Author's Molecular cloning of chicken myosin-binding protein (MyBP) H (86-kDa protein) reveals extensive homology with MyBP-C (C-protein) with conserved immunoglobulin C2 and fibronectin type III motifs.‏
670 ‎‡a Author's N-methyl pyrrolidone‏
670 ‎‡a Author's N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration.‏
670 ‎‡a Author's N-methyl pyrrolidone/bone morphogenetic protein-2 double delivery with in situ forming implants‏
670 ‎‡a Author's N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling.‏
670 ‎‡a Author's N,N-Dimethlyacetamide Prevents the High-Fat Diet-Induced Increase in Body Weight‏
670 ‎‡a Author's N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment‏
670 ‎‡a Author's Novel membrane for guided bone regeneration.‏
670 ‎‡a Author's Osteoconductive Microarchitecture of Bone Substitutes for Bone Regeneration Revisited‏
670 ‎‡a Author's Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2‏
670 ‎‡a Author's Preclinical in vivo Performance of Novel Biodegradable, Electrospun Poly(lactic acid) and Poly(lactic-co-glycolic acid) Nanocomposites: A Review.‏
670 ‎‡a Author's Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma?‏
670 ‎‡a Author's Properties and Mechanobiological Behavior of Bovine Nasal Septum Cartilage.‏
670 ‎‡a Author's Pulp-Derived Exosomes in a Fibrin-Based Regenerative Root Filling Material‏
670 ‎‡a Author's Rapid up- and down-regulation of hexokinase II in rat skeletal muscle in response to altered contractile activity‏
670 ‎‡a Author's Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics‏
670 ‎‡a Author's Reconsidering Osteoconduction in the Era of Additive Manufacturing‏
670 ‎‡a Author's Reconstitution and further characterization of the cholesterol transport activity of the small-intestinal brush border membrane‏
670 ‎‡a Author's Regenerative Dentistry: Animal Model for Regenerative Endodontology.‏
670 ‎‡a Author's Repair of bone defects using synthetic mimetics of collagenous extracellular matrices‏
670 ‎‡a Author's Role of HTRA1 in bone formation and regeneration: In vitro and in vivo evaluation.‏
670 ‎‡a Author's Screening recurrence and lymph node metastases in head and neck cancer: the role of computer tomography in follow-up.‏
670 ‎‡a Author's Similar inductive effects of enamel and dentin matrix derivatives on osteoblast-like cell response over SLA titanium surface‏
670 ‎‡a Author's Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly‏
670 ‎‡a Author's Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres‏
670 ‎‡a Author's Synthetic extracellular matrices for in situ tissue engineering‏
670 ‎‡a Author's Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics‏
670 ‎‡a Author's The Bromodomain Inhibitor -Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes‏
670 ‎‡a Author's The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model.‏
670 ‎‡a Author's The epigenetically active small chemical N-methyl pyrrolidone‏
670 ‎‡a Author's The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis‏
670 ‎‡a Author's The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif.‏
670 ‎‡a Author's The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model‏
670 ‎‡a Author's The uptake of cholesterol at the small-intestinal brush border membrane is inhibited by apolipoproteins‏
670 ‎‡a Author's The Use of Adipose Tissue-Derived Progenitors in Bone Tissue Engineering - a Review‏
670 ‎‡a Author's The zirconia implant-bone interface: a preliminary histologic evaluation in rabbits.‏
670 ‎‡a Author's Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix‏
909 ‎‡a (scopus) 55317043700‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000316702296‏ ‎‡9 1‏
919 ‎‡a nmethylpyrrolidone‏ ‎‡A N-methyl pyrrolidone‏ ‎‡9 1‏
919 ‎‡a ceriumchlorideapplicationpromoteswoundhealingandcellproliferationinhumanforeskinfibroblasts‏ ‎‡A Cerium Chloride Application Promotes Wound Healing and Cell Proliferation in Human Foreskin Fibroblasts.‏ ‎‡9 1‏
919 ‎‡a useofadiposetissuederivedprogenitorsinbonetissueengineeringareview‏ ‎‡A The Use of Adipose Tissue-Derived Progenitors in Bone Tissue Engineering - a Review‏ ‎‡9 1‏
919 ‎‡a preclinicalinvivoperformanceofnovelbiodegradableelectrospunpolylacticacidandpolylacticcoglycolicacidnanocompositesareview‏ ‎‡A Preclinical in vivo Performance of Novel Biodegradable, Electrospun Poly(lactic acid) and Poly(lactic-co-glycolic acid) Nanocomposites: A Review.‏ ‎‡9 1‏
919 ‎‡a regenerativedentistryanimalmodelforregenerativeendodontology‏ ‎‡A Regenerative Dentistry: Animal Model for Regenerative Endodontology.‏ ‎‡9 1‏
919 ‎‡a rapidupanddownregulationofhexokinase2inratskeletalmuscleinresponsetoalteredcontractileactivity‏ ‎‡A Rapid up- and down-regulation of hexokinase II in rat skeletal muscle in response to altered contractile activity‏ ‎‡9 1‏
919 ‎‡a similarinductiveeffectsofenamelanddentinmatrixderivativesonosteoblastlikecellresponseoverslatitaniumsurface‏ ‎‡A Similar inductive effects of enamel and dentin matrix derivatives on osteoblast-like cell response over SLA titanium surface‏ ‎‡9 1‏
919 ‎‡a syntheticmatrixmetalloproteinasesensitivehydrogelsfortheconductionoftissueregenerationengineeringcellinvasioncharacteristics‏ ‎‡A Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics‏ ‎‡9 1‏
919 ‎‡a epigeneticallyactivesmallchemicalnmethylpyrrolidonenmppreventsestrogendepletioninducedosteoporosis‏ ‎‡A The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis‏ ‎‡9 1‏
919 ‎‡a modelsystemofthedynamicloadingoccurringinsynovialjointsthebiologicaleffectofplowingonpristinecartilage‏ ‎‡A A model system of the dynamic loading occurring in synovial joints: the biological effect of plowing on pristine cartilage‏ ‎‡9 1‏
919 ‎‡a absorptionofmonoacylglycerolsbysmallintestinalbrushbordermembrane‏ ‎‡A Absorption of monoacylglycerols by small intestinal brush border membrane‏ ‎‡9 1‏
919 ‎‡a biodegradationsoftandhardtissueintegrationofvariouspolyethyleneglycolhydrogelsahistomorphometricstudyinrabbits‏ ‎‡A Biodegradation, soft and hard tissue integration of various polyethylene glycol hydrogels: a histomorphometric study in rabbits.‏ ‎‡9 1‏
919 ‎‡a invivoandinvitroevaluationofflexiblecottonwoollikenanocompositesasbonesubstitutematerialforcomplexdefects‏ ‎‡A In vivo and in vitro evaluation of flexible, cottonwool-like nanocomposites as bone substitute material for complex defects‏ ‎‡9 1‏
919 ‎‡a bmp2andbmp27heterodimersconjugatedtoafibrinhyaluronicacidhydrogelinalargeanimalmodelofmildintervertebraldiscdegeneration‏ ‎‡A BMP-2 and BMP-2/7 Heterodimers Conjugated to a Fibrin/Hyaluronic Acid Hydrogel in a Large Animal Model of Mild Intervertebral Disc Degeneration.‏ ‎‡9 1‏
919 ‎‡a boneregenerationbytheosteoconductivityofporoustitaniumimplantsmanufacturedbyselectivelasermeltingahistologicalandmicrocomputedtomographystudyintherabbit‏ ‎‡A Bone regeneration by the osteoconductivity of porous titanium implants manufactured by selective laser melting: a histological and micro computed tomography study in the rabbit.‏ ‎‡9 1‏
919 ‎‡a bonerepairwithaformofbmp2engineeredforincorporationintofibrincellingrowthmatrices‏ ‎‡A Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices.‏ ‎‡9 1‏
919 ‎‡a enzymemediatedsitespecificsurfacemodification‏ ‎‡A Enzyme mediated site-specific surface modification.‏ ‎‡9 1‏
919 ‎‡a fibrinhydrogelbasedbonesubstitutetetheredwithbmp2andbmp27heterodimers‏ ‎‡A Fibrin Hydrogel Based Bone Substitute Tethered with BMP-2 and BMP-2/7 Heterodimers‏ ‎‡9 1‏
919 ‎‡a humanmyosinbindingproteinhmybphcompleteprimarysequencegenomicorganizationandchromosomallocalization‏ ‎‡A Human myosin-binding protein H (MyBP-H): complete primary sequence, genomic organization, and chromosomal localization‏ ‎‡9 1‏
919 ‎‡a highpowerpulsedndyaglaserasanewstimulustoinducebmp2expressioninmc3t3e1osteoblasts‏ ‎‡A High power-pulsed Nd:YAG laser as a new stimulus to induce BMP-2 expression in MC3T3-E1 osteoblasts‏ ‎‡9 1‏
919 ‎‡a erratumlongitudinalinvivoevaluationofboneregenerationbycombinedmeasurementofmultipinholespectandmicroctfortissueengineering‏ ‎‡A Erratum: Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering‏ ‎‡9 1‏
919 ‎‡a evaluationofmoldableinsituhardeningcalciumphosphatebonegraftsubstitutes‏ ‎‡A Evaluation of moldable, in situ hardening calcium phosphate bone graft substitutes‏ ‎‡9 1‏
919 ‎‡a boneregenerationusingasyntheticmatrixcontainingenamelmatrixderivate‏ ‎‡A Bone regeneration using a synthetic matrix containing enamel matrix derivate‏ ‎‡9 1‏
919 ‎‡a heterotopicboneformationaroundvesselspilotstudyofanewanimalmodel‏ ‎‡A Heterotopic bone formation around vessels: pilot study of a new animal model‏ ‎‡9 1‏
919 ‎‡a functionalizationofceramicscaffoldswithexosomesfrombonemarrowmesenchymalstromalcellsforbonetissueengineering‏ ‎‡A Functionalization of Ceramic Scaffolds with Exosomes from Bone Marrow Mesenchymal Stromal Cells for Bone Tissue Engineering‏ ‎‡9 1‏
919 ‎‡a epigeneticdrugsasnewtherapyfortumornecrosisfactorαcompromisedbonehealing‏ ‎‡A Epigenetic drugs as new therapy for tumor necrosis factor-α-compromised bone healing‏ ‎‡9 1‏
919 ‎‡a bonesubstitutes‏ ‎‡A [Bone substitutes]‏ ‎‡9 1‏
919 ‎‡a guidedboneregenerationwithasyntheticbiodegradablemembraneacomparativestudyindogs‏ ‎‡A Guided bone regeneration with a synthetic biodegradable membrane: a comparative study in dogs‏ ‎‡9 1‏
919 ‎‡a heterodimericbmp27fornucleuspulposusregenerationinvitroandexvivostudies‏ ‎‡A Heterodimeric BMP-2/7 for nucleus pulposus regeneration-In vitro and ex vivo studies.‏ ‎‡9 1‏
919 ‎‡a bonemorphogeneticprotein2enhancesboneformationwhendeliveredbyasyntheticmatrixcontaininghydroxyapatitetricalciumphosphate‏ ‎‡A Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate‏ ‎‡9 1‏
919 ‎‡a biomimeticconditioningofhumandentinusingcitricacid‏ ‎‡A Biomimetic Conditioning of Human Dentin Using Citric Acid‏ ‎‡9 1‏
919 ‎‡a boneregenerationinthepresenceofasynthetichydroxyapatitesilicaoxidebasedandaxenogenichydroxyapatitebasedbonesubstitutematerial‏ ‎‡A Bone regeneration in the presence of a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute material‏ ‎‡9 1‏
919 ‎‡a influenceofnmethylpyrrolidoneontheactivityofthepulpdentinecomplexandboneintegrityduringosteoporosis‏ ‎‡A Influence of N-methyl pyrrolidone on the activity of the pulp-dentine complex and bone integrity during osteoporosis‏ ‎‡9 1‏
919 ‎‡a molecularcloningofaperoxisomalca2+dependentmemberofthemitochondrialcarriersuperfamily‏ ‎‡A Molecular cloning of a peroxisomal Ca 2+ -dependent member of the mitochondrial carrier superfamily‏ ‎‡9 2‏
919 ‎‡a biomolecularhydrogelsformedanddegradedviasitespecificenzymaticreactions‏ ‎‡A Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions‏ ‎‡9 1‏
919 ‎‡a impactofrecombinantplateletderivedgrowthfactorbbonboneregenerationastudyinrabbits‏ ‎‡A Impact of recombinant platelet-derived growth factor BB on bone regeneration: a study in rabbits.‏ ‎‡9 1‏
919 ‎‡a boneaugmentationusingasynthetichydroxyapatitesilicaoxidebasedandaxenogenichydroxyapatitebasedbonesubstitutematerialswithandwithoutrecombinanthumanbonemorphogeneticprotein2‏ ‎‡A Bone augmentation using a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute materials with and without recombinant human bone morphogenetic protein-2‏ ‎‡9 1‏
919 ‎‡a inpresterolcarrierprotein2scp2insolutiontheleaderpeptide120isflexiblydisorderedandresidues21143adoptthesameglobularfoldasinmaturescp2‏ ‎‡A In pre-sterol carrier protein 2 (SCP2) in solution the leader peptide 1-20 is flexibly disordered, and residues 21-143 adopt the same globular fold as in mature SCP2‏ ‎‡9 1‏
919 ‎‡a cdnacloningandsequencecomparisonsofhumanandchickenmuscle100proteinand86kdprotein‏ ‎‡A cDNA cloning and sequence comparisons of human and chicken muscle C-protein and 86kD protein‏ ‎‡9 1‏
919 ‎‡a bonehealingintheratanddogwithnonglycosylatedbmp2demonstratinglowsolubilityinfibrinmatrices‏ ‎‡A Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices‏ ‎‡9 1‏
919 ‎‡a introductionoftheanspachdrillasanovelsurgicaldrillerforcreatingcalvarialdefectsinanimalmodels‏ ‎‡A Introduction of the Anspach drill as a novel surgical driller for creating calvarial defects in animal models‏ ‎‡9 1‏
919 ‎‡a microporositiesin3dprintedtricalciumphosphatebasedbonesubstitutesenhanceosteoconductionandaffectosteoclasticresorption‏ ‎‡A Microporosities in 3D-Printed Tricalcium-Phosphate-Based Bone Substitutes Enhance Osteoconduction and Affect Osteoclastic Resorption‏ ‎‡9 1‏
919 ‎‡a inhibitionofosteoclastdifferentiationandboneresorptionbynmethylpyrrolidone‏ ‎‡A Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone‏ ‎‡9 1‏
919 ‎‡a mechanicalloadingofmousecaudalvertebraeincreasestrabecularandcorticalbonemassdependenceondoseandgenotype‏ ‎‡A Mechanical loading of mouse caudal vertebrae increases trabecular and cortical bone mass-dependence on dose and genotype.‏ ‎‡9 1‏
919 ‎‡a iodixanolasacontrastagentinafibrinhydrogelforendodonticapplications‏ ‎‡A Iodixanol as a Contrast Agent in a Fibrin Hydrogel for Endodontic Applications.‏ ‎‡9 1‏
919 ‎‡a latticemicroarchitectureforbonetissueengineeringfromcalciumphosphatecomparedtotitanium‏ ‎‡A Lattice Microarchitecture for Bone Tissue Engineering from Calcium Phosphate Compared to Titanium‏ ‎‡9 1‏
919 ‎‡a longitudinalinvivoevaluationofboneregenerationbycombinedmeasurementofmultipinholespectandmicroctfortissueengineering‏ ‎‡A Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering‏ ‎‡9 1‏
919 ‎‡a comparativestudyofsterolabsorptionindifferentsmallintestinalbrushbordermembranemodels‏ ‎‡A A comparative study of sterol absorption in different small-intestinal brush border membrane models‏ ‎‡9 1‏
919 ‎‡a noveltissueocclusivepolyethyleneglycolhydrogelmaterial‏ ‎‡A A novel, tissue occlusive poly(ethylene glycol) hydrogel material‏ ‎‡9 1‏
919 ‎‡a characterizationoflipidexchangeproteinsisolatedfromsmallintestinalbrushbordermembrane‏ ‎‡A Characterization of lipid exchange proteins isolated from small intestinal brush border membrane‏ ‎‡9 1‏
919 ‎‡a designconstructionandvalidationofacomputercontrolledsystemforfunctionalloadingofsofttissue‏ ‎‡A Design, construction and validation of a computer controlled system for functional loading of soft tissue‏ ‎‡9 1‏
919 ‎‡a randomizedcontrolledclinicaltrialevaluatingclinicalandradiologicaloutcomesafter3and5yearsofdentalimplantsplacedinboneregeneratedbymeansofgbrtechniqueswithorwithouttheadditionofbmp2‏ ‎‡A A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2‏ ‎‡9 1‏
919 ‎‡a biodegradationandtissueintegrationofvariouspolyethyleneglycolmatricesacomparativestudyinrabbits‏ ‎‡A Biodegradation and tissue integration of various polyethylene glycol matrices: a comparative study in rabbits.‏ ‎‡9 1‏
919 ‎‡a molecularcloningofchickenmyosinbindingproteinmybph86kdaproteinrevealsextensivehomologywithmybp100100proteinwithconservedimmunoglobulinc2andfibronectintype3motifs‏ ‎‡A Molecular cloning of chicken myosin-binding protein (MyBP) H (86-kDa protein) reveals extensive homology with MyBP-C (C-protein) with conserved immunoglobulin C2 and fibronectin type III motifs.‏ ‎‡9 1‏
919 ‎‡a comparisonofcholesterolandsitosteroluptakeindifferentbrushbordermembranemodels‏ ‎‡A Comparison of cholesterol and sitosterol uptake in different brush border membrane models‏ ‎‡9 1‏
919 ‎‡a analysisofhydrolyzablepolyethyleneglycolhydrogelsanddeproteinizedbonemineralasdeliverysystemsforglycosylatedandnonglycosylatedbonemorphogeneticprotein2‏ ‎‡A Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2.‏ ‎‡9 1‏
919 ‎‡a deliveryofbmp2by2clinicallyavailableapatitematerialsinvitroandinvivocomparison‏ ‎‡A Delivery of BMP-2 by two clinically available apatite materials: in vitro and in vivo comparison‏ ‎‡9 1‏
919 ‎‡a cholesterylesterabsorptionbysmallintestinalbrushbordermembraneisproteinmediated‏ ‎‡A Cholesteryl ester absorption by small intestinal brush border membrane is protein-mediated‏ ‎‡9 1‏
919 ‎‡a comparativestudyofnmppreloadedanddiploadedmembranesforguidedboneregenerationofrabbitcranialdefects‏ ‎‡A Comparative study of NMP-preloaded and dip-loaded membranes for guided bone regeneration of rabbit cranial defects‏ ‎‡9 1‏
919 ‎‡a comparisonof2resorbablemembranesystemsinboneregenerationafterremovalofwisdomteetharandomizedcontrolledclinicalpilotstudy‏ ‎‡A Comparison of two resorbable membrane systems in bone regeneration after removal of wisdom teeth: a randomized-controlled clinical pilot study‏ ‎‡9 1‏
919 ‎‡a contractileactivityenhancesthesynthesisofhexokinase2inratskeletalmuscle‏ ‎‡A Contractile activity enhances the synthesis of hexokinase II in rat skeletal muscle‏ ‎‡9 1‏
919 ‎‡a couplingplowingofcartilageexplantswithgeneexpressioninmodelsforsynovialjoints‏ ‎‡A Coupling plowing of cartilage explants with gene expression in models for synovial joints.‏ ‎‡9 1‏
919 ‎‡a immobilizationofchondroitinsulfatetolipidmembranesanditsinteractionswithecmproteins‏ ‎‡A Immobilization of chondroitin sulfate to lipid membranes and its interactions with ECM proteins‏ ‎‡9 1‏
919 ‎‡a effectofrhbmp2onguidedboneregenerationinhumans‏ ‎‡A Effect of rhBMP-2 on guided bone regeneration in humans.‏ ‎‡9 1‏
919 ‎‡a dietarytocotrienolsreduceconcentrationsofplasmacholesterolapolipoproteinbthromboxaneb2andplateletfactor4inpigswithinheritedhyperlipidemias‏ ‎‡A Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias.‏ ‎‡9 1‏
919 ‎‡a effectofceriumchlorideapplicationonfibroblastandosteoblastproliferationanddifferentiation‏ ‎‡A Effect of cerium chloride application on fibroblast and osteoblast proliferation and differentiation.‏ ‎‡9 1‏
919 ‎‡a effectofdifferentrhbmp2andtgvegfratiosontheformationofheterotopicboneandneovessels‏ ‎‡A Effect of different rhBMP-2 and TG-VEGF ratios on the formation of heterotopic bone and neovessels.‏ ‎‡9 1‏
919 ‎‡a effectofdirectcurrentonsurfacestructureandcytocompatibilityoftitaniumdentalimplants‏ ‎‡A Effect of direct current on surface structure and cytocompatibility of titanium dental implants‏ ‎‡9 1‏
919 ‎‡a nmethylpyrrolidoneasapotentbonemorphogeneticproteinenhancerforbonetissueregeneration‏ ‎‡A N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration.‏ ‎‡9 1‏
919 ‎‡a enzymaticformationofmodularcellinstructivefibrinanalogsfortissueengineering‏ ‎‡A Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering.‏ ‎‡9 1‏
919 ‎‡a effectofshorttimepovidoneiodineapplicationonosteoblastproliferationanddifferentiation‏ ‎‡A Effect of short-time povidone-iodine application on osteoblast proliferation and differentiation.‏ ‎‡9 1‏
919 ‎‡a effectsofstemcellfactoroncellhomingduringfunctionalpulpregenerationinhumanimmatureteeth‏ ‎‡A Effects of Stem Cell Factor on Cell Homing During Functional Pulp Regeneration in Human Immature Teeth‏ ‎‡9 1‏
919 ‎‡a elucidatingtheroleofmatrixstiffnessin3dcellmigrationandremodeling‏ ‎‡A Elucidating the role of matrix stiffness in 3D cell migration and remodeling.‏ ‎‡9 1‏
919 ‎‡a engineering3dcellinstructivemicroenvironmentsbyrationalassemblyofartificialextracellularmatricesandcellpatterning‏ ‎‡A Engineering 3D cell instructive microenvironments by rational assembly of artificial extracellular matrices and cell patterning‏ ‎‡9 1‏
919 ‎‡a enhancedosteoblasticactivityandboneregenerationusingsurfacemodifiedporousbioactiveglassscaffolds‏ ‎‡A Enhanced osteoblastic activity and bone regeneration using surface-modified porous bioactive glass scaffolds‏ ‎‡9 1‏
919 ‎‡a randomizedcontrolledclinicalmulticentertrialcomparingtheclinicalandhistologicalperformanceofanewmodifiedpolylactidecoglycolideacidmembranetoanexpandedpolytetrafluorethylenemembraneinguidedboneregenerationprocedures‏ ‎‡A A randomized controlled clinical multicenter trial comparing the clinical and histological performance of a new, modified polylactide-co-glycolide acid membrane to an expanded polytetrafluorethylene membrane in guided bone regeneration procedures‏ ‎‡9 1‏
919 ‎‡a biomimeticpeghydrogelscrosslinkedwithminimalplasminsensitivetriaminoacidpeptides‏ ‎‡A Biomimetic PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides‏ ‎‡9 1‏
919 ‎‡a uptakeofcholesterolatthesmallintestinalbrushbordermembraneisinhibitedbyapolipoproteins‏ ‎‡A The uptake of cholesterol at the small-intestinal brush border membrane is inhibited by apolipoproteins‏ ‎‡9 1‏
919 ‎‡a boneregenerationusingasyntheticmatrixcontainingaparathyroidhormonepeptidecombinedwithagraftingmaterial‏ ‎‡A Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material‏ ‎‡9 1‏
919 ‎‡a campenhancesbmp2signalingthroughpkaandmkp1dependentmechanisms‏ ‎‡A cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms.‏ ‎‡9 1‏
919 ‎‡a cellfreetranslationofbalbianiringrna75sofchironomustentanssalivaryglandsintohighmolecularweightproducts‏ ‎‡A Cell-Free translation of Balbiani ring RNA (75S) ofChironomus tentans salivary glands into high molecular weight products‏ ‎‡9 1‏
919 ‎‡a changesinfreeandboundformsandtotalamountofhexokinaseisozyme2ofratmuscleinresponsetocontractileactivity‏ ‎‡A Changes in free and bound forms and total amount of hexokinase isozyme II of rat muscle in response to contractile activity‏ ‎‡9 1‏
919 ‎‡a deletionmutantsofbmpfoldingvariantsactasbmpantagonistsandareefficientinhibitorsforheterotopicossification‏ ‎‡A Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.‏ ‎‡9 1‏
919 ‎‡a effectofplateletderivedgrowthfactorbbontissueintegrationofcrosslinkedandnoncrosslinkedcollagenmatricesinaratectopicmodel‏ ‎‡A Effect of platelet-derived growth factor-BB on tissue integration of cross-linked and non-cross-linked collagen matrices in a rat ectopic model.‏ ‎‡9 1‏
919 ‎‡a syntheticextracellularmatricesforinsitutissueengineering‏ ‎‡A Synthetic extracellular matrices for in situ tissue engineering‏ ‎‡9 1‏
919 ‎‡a enhancementofbonehealingusingnonglycosylatedrhbmp2releasedfromafibrinmatrixindogsandcats‏ ‎‡A Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats‏ ‎‡9 1‏
919 ‎‡a epigeneticregulationofboneremodelinganditsimpactsinosteoporosis‏ ‎‡A Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis‏ ‎‡9 1‏
919 ‎‡a evaluationofaninsituformedsynthetichydrogelasabiodegradablemembraneforguidedboneregeneration‏ ‎‡A Evaluation of an in situ formed synthetic hydrogel as a biodegradable membrane for guided bone regeneration‏ ‎‡9 1‏
919 ‎‡a fibringelimprovestissueingrowthandcelldifferentiationinhumanimmaturepremolarsimplantedinrats‏ ‎‡A Fibrin gel improves tissue ingrowth and cell differentiation in human immature premolars implanted in rats.‏ ‎‡9 1‏
919 ‎‡a screeningrecurrenceandlymphnodemetastasesinheadandneckcancertheroleofcomputertomographyinfollowup‏ ‎‡A Screening recurrence and lymph node metastases in head and neck cancer: the role of computer tomography in follow-up.‏ ‎‡9 1‏
919 ‎‡a identificationofareceptormediatingabsorptionofdietarycholesterolintheintestine‏ ‎‡A Identification of a receptor mediating absorption of dietary cholesterol in the intestine‏ ‎‡9 1‏
919 ‎‡a intraoperativeengineeringofosteogenicgraftscombiningfreshlyharvestedhumanadiposederivedcellsandphysiologicaldosesofbonemorphogeneticprotein2‏ ‎‡A Intraoperative engineering of osteogenic grafts combining freshly harvested, human adipose-derived cells and physiological doses of bone morphogenetic protein-2‏ ‎‡9 1‏
919 ‎‡a reconstitutionandfurthercharacterizationofthecholesteroltransportactivityofthesmallintestinalbrushbordermembrane‏ ‎‡A Reconstitution and further characterization of the cholesterol transport activity of the small-intestinal brush border membrane‏ ‎‡9 1‏
919 ‎‡a nmethylpyrrolidonebonemorphogeneticprotein2doubledeliverywithinsituformingimplants‏ ‎‡A N-methyl pyrrolidone/bone morphogenetic protein-2 double delivery with in situ forming implants‏ ‎‡9 1‏
919 ‎‡a nndimethlyacetamidepreventsthehighfatdietinducedincreaseinbodyweight‏ ‎‡A N,N-Dimethlyacetamide Prevents the High-Fat Diet-Induced Increase in Body Weight‏ ‎‡9 1‏
919 ‎‡a novelmembraneforguidedboneregeneration‏ ‎‡A Novel membrane for guided bone regeneration.‏ ‎‡9 1‏
919 ‎‡a pulpderivedexosomesinafibrinbasedregenerativerootfillingmaterial‏ ‎‡A Pulp-Derived Exosomes in a Fibrin-Based Regenerative Root Filling Material‏ ‎‡9 1‏
919 ‎‡a pretreatmentthrombocytosisaprognosticmarkerfororalsquamouscellcarcinoma‏ ‎‡A Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma?‏ ‎‡9 1‏
919 ‎‡a osteoconductivemicroarchitectureofbonesubstitutesforboneregenerationrevisited‏ ‎‡A Osteoconductive Microarchitecture of Bone Substitutes for Bone Regeneration Revisited‏ ‎‡9 1‏
919 ‎‡a recombinantproteincopegnetworksascelladhesiveandproteolyticallydegradablehydrogelmatrixespart2biofunctionalcharacteristics‏ ‎‡A Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics‏ ‎‡9 1‏
919 ‎‡a repairofbonedefectsusingsyntheticmimeticsofcollagenousextracellularmatrices‏ ‎‡A Repair of bone defects using synthetic mimetics of collagenous extracellular matrices‏ ‎‡9 1‏
919 ‎‡a propertiesandmechanobiologicalbehaviorofbovinenasalseptumcartilage‏ ‎‡A Properties and Mechanobiological Behavior of Bovine Nasal Septum Cartilage.‏ ‎‡9 1‏
919 ‎‡a nndimethylacetamideadrugexcipientthatactsasbromodomainligandforosteoporosistreatment‏ ‎‡A N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment‏ ‎‡9 1‏
919 ‎‡a slowandcontinuousapplicationofhumanrecombinantbonemorphogeneticproteinviabiodegradablepoly‏ ‎‡A Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly‏ ‎‡9 1‏
919 ‎‡a invitroresponseofprimaryhumanbonemarrowstromalcellstorecombinanthumanbonemorphogenicprotein2intheearlyandlatestagesofosteoblastdifferentiation‏ ‎‡A In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation‏ ‎‡9 1‏
919 ‎‡a reconsideringosteoconductionintheeraofadditivemanufacturing‏ ‎‡A Reconsidering Osteoconduction in the Era of Additive Manufacturing‏ ‎‡9 1‏
919 ‎‡a plateletrichplasmaandfibrinasdeliverysystemsforrecombinanthumanbonemorphogeneticprotein2‏ ‎‡A Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2‏ ‎‡9 1‏
919 ‎‡a bromodomaininhibitormethylpyrrolidonepreventsosteoporosisandbmptriggeredsclerostinexpressioninosteocytes‏ ‎‡A The Bromodomain Inhibitor -Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes‏ ‎‡9 1‏
919 ‎‡a epigeneticallyactivesmallchemicalnmethylpyrrolidone‏ ‎‡A The epigenetically active small chemical N-methyl pyrrolidone‏ ‎‡9 1‏
919 ‎‡a roleofhtra1inboneformationandregenerationinvitroandinvivoevaluation‏ ‎‡A Role of HTRA1 in bone formation and regeneration: In vitro and in vivo evaluation.‏ ‎‡9 1‏
919 ‎‡a effectsofμctradiationontissueengineeredbonelikeconstructs‏ ‎‡A Effects of μCT radiation on tissue engineered bone-like constructs.‏ ‎‡9 1‏
919 ‎‡a majormyosinbindingdomainofskeletalmusclemybp100100proteinresidesinthecoohterminalimmunoglobulinc2motif‏ ‎‡A The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif.‏ ‎‡9 1‏
919 ‎‡a disulfidebridgeconformersofmaturebmpareinhibitorsforheterotopicossification‏ ‎‡A Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification.‏ ‎‡9 1‏
919 ‎‡a slowandcontinuousapplicationofhumanrecombinantbonemorphogeneticproteinviabiodegradablepolylactidecoglycolidefoamspheres‏ ‎‡A Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres‏ ‎‡9 1‏
919 ‎‡a zirconiaimplantboneinterfaceapreliminaryhistologicevaluationinrabbits‏ ‎‡A The zirconia implant-bone interface: a preliminary histologic evaluation in rabbits.‏ ‎‡9 1‏
919 ‎‡a bromodomaininhibitornmethylpyrrolidonereducedfataccumulationinanovariectomizedratmodel‏ ‎‡A The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model.‏ ‎‡9 1‏
919 ‎‡a treatmentofnonunionswithnonglycosylatedrecombinanthumanbonemorphogeneticprotein2deliveredfromafibrinmatrix‏ ‎‡A Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix‏ ‎‡9 1‏
919 ‎‡a nmethylpyrrolidonenmpinhibitslipopolysaccharideinducedinflammationbysuppressingnfκbsignaling‏ ‎‡A N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling.‏ ‎‡9 1‏
919 ‎‡a automaticregistrationof2dhistologicalsectionsto3dmicroctvolumestrabecularbone‏ ‎‡A Automatic registration of 2D histological sections to 3D microCT volumes: Trabecular bone‏ ‎‡9 1‏
919 ‎‡a releaseofthebromodomainligandnndimethylacetamideaddsbioactivitytoaresorbableguidedboneregenerationmembraneinarabbitcalvarialdefectmodel‏ ‎‡A The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 87855664
996 ‎‡2 ISNI|0000000012803821
996 ‎‡2 DNB|1052713327
996 ‎‡2 BAV|495_377596
996 ‎‡2 ISNI|0000000013243301
996 ‎‡2 JPG|500026367
996 ‎‡2 SUDOC|153013834
996 ‎‡2 DNB|120254715X
996 ‎‡2 SUDOC|056921497
996 ‎‡2 ISNI|0000000012575945
996 ‎‡2 DNB|1337684708
996 ‎‡2 SIMACOB|202696291
996 ‎‡2 BIBSYS|90396041
996 ‎‡2 ISNI|0000000010563633
996 ‎‡2 DNB|1182567460
996 ‎‡2 ISNI|0000000060813370
996 ‎‡2 RERO|A023047565
996 ‎‡2 J9U|987007274748905171
996 ‎‡2 DNB|127292977
996 ‎‡2 SUDOC|197232779
996 ‎‡2 NII|DA12374813
996 ‎‡2 ISNI|0000000072440903
996 ‎‡2 DNB|118765825
996 ‎‡2 DNB|1143158237
996 ‎‡2 DNB|1084656647
996 ‎‡2 BIBSYS|90378218
996 ‎‡2 DNB|138185360
996 ‎‡2 SUDOC|080157289
996 ‎‡2 BIBSYS|1615358753721
996 ‎‡2 NTA|07143271X
996 ‎‡2 DNB|142696935
996 ‎‡2 J9U|987007294159105171
996 ‎‡2 PLWABN|9812403655005606
996 ‎‡2 DNB|121284964
996 ‎‡2 DNB|123191416
996 ‎‡2 ISNI|0000000072643145
996 ‎‡2 ISNI|0000000081370038
996 ‎‡2 ISNI|0000000101240338
996 ‎‡2 NUKAT|n 2007009084
996 ‎‡2 DNB|104361608X
996 ‎‡2 SUDOC|160971055
996 ‎‡2 PLWABN|9810610083205606
996 ‎‡2 BNF|17842567
996 ‎‡2 NKC|jn20010601907
996 ‎‡2 RERO|A013702813
996 ‎‡2 LC|nr 00003569
996 ‎‡2 SUDOC|147776430
996 ‎‡2 LC|n 87808437
996 ‎‡2 ISNI|0000000081100273
996 ‎‡2 DNB|117158542
996 ‎‡2 DNB|131793624
996 ‎‡2 CAOONL|ncf11880905
996 ‎‡2 ISNI|0000000359111963
996 ‎‡2 BIBSYS|97031808
996 ‎‡2 DNB|142175838
996 ‎‡2 BIBSYS|14030782
996 ‎‡2 ISNI|0000000447403878
996 ‎‡2 DNB|17102138X
996 ‎‡2 NUKAT|n 2015147089
996 ‎‡2 DNB|1284899683
996 ‎‡2 CAOONL|ncf11224106
996 ‎‡2 DNB|1220107808
996 ‎‡2 DNB|1208213105
996 ‎‡2 LC|n 81101187
996 ‎‡2 DNB|1193277639
996 ‎‡2 LC|no2018013566
996 ‎‡2 ISNI|0000000000652210
996 ‎‡2 SUDOC|112647405
996 ‎‡2 ISNI|0000000015604529
996 ‎‡2 DNB|104075953
996 ‎‡2 LC|n 2009046756
996 ‎‡2 DNB|123529263
996 ‎‡2 LC|no 88002463
996 ‎‡2 DNB|134018605
996 ‎‡2 BAV|495_182676
996 ‎‡2 SUDOC|098050028
996 ‎‡2 NKC|xx0020218
996 ‎‡2 DE633|pe41022605
996 ‎‡2 LC|n 99026180
996 ‎‡2 BIBSYS|14799
996 ‎‡2 ISNI|0000000034970436
996 ‎‡2 NTA|275125920
996 ‎‡2 BNCHL|10000000000000000175453
996 ‎‡2 DNB|117157678
996 ‎‡2 BIBSYS|1059443
996 ‎‡2 DE633|pe30064184
996 ‎‡2 NII|DA08358187
996 ‎‡2 DE633|pe30056183
996 ‎‡2 DNB|1330632222
996 ‎‡2 DNB|130840653
996 ‎‡2 DNB|189459158
996 ‎‡2 DNB|126673829
996 ‎‡2 RERO|A016652084
996 ‎‡2 ISNI|0000000111540342
996 ‎‡2 ISNI|000000008397015X
996 ‎‡2 NKC|nlk20000084893
996 ‎‡2 SUDOC|136747930
996 ‎‡2 DNB|1201124557
996 ‎‡2 DNB|101292562
996 ‎‡2 PLWABN|9812197557005606
996 ‎‡2 NTA|067667376
996 ‎‡2 ISNI|000000038804064X
996 ‎‡2 SUDOC|255712995
996 ‎‡2 ISNI|0000000048606846
996 ‎‡2 ISNI|0000000047200473
996 ‎‡2 PLWABN|9810667169505606
996 ‎‡2 NTA|068654014
996 ‎‡2 LC|n 81033900
996 ‎‡2 RERO|A018986772
996 ‎‡2 NTA|192660624
996 ‎‡2 DNB|116723785
996 ‎‡2 DNB|134571193X
996 ‎‡2 BIBSYS|90310707
996 ‎‡2 DNB|124272878
996 ‎‡2 BNF|12484777
996 ‎‡2 PLWABN|9810530618005606
996 ‎‡2 ISNI|0000000486277288
996 ‎‡2 DNB|11715850X
996 ‎‡2 SIMACOB|1219427
996 ‎‡2 BNF|14980584
996 ‎‡2 DNB|13818559X
996 ‎‡2 DNB|1053490666
996 ‎‡2 DNB|1079567267
996 ‎‡2 NUKAT|n 2007126029
996 ‎‡2 RERO|A012084668
996 ‎‡2 DNB|117158844
996 ‎‡2 DNB|127293019
996 ‎‡2 DNB|1349033383
996 ‎‡2 DNB|1216748322
996 ‎‡2 J9U|987012851554405171
996 ‎‡2 DNB|125585393X
996 ‎‡2 DNB|1274267463
996 ‎‡2 DNB|133087434X
996 ‎‡2 NTA|262211173
996 ‎‡2 ISNI|0000000014838489
996 ‎‡2 DNB|172428742
996 ‎‡2 LC|no2014067183
996 ‎‡2 ISNI|0000000097355449
996 ‎‡2 BNF|13901051
996 ‎‡2 LC|n 2013067743
996 ‎‡2 DNB|107339543X
996 ‎‡2 NTA|189495359
996 ‎‡2 NTA|161818862
996 ‎‡2 RERO|A000175512
996 ‎‡2 DNB|1273496388
996 ‎‡2 BIBSYS|99034622
996 ‎‡2 DNB|135588235
996 ‎‡2 LC|no2008106006
996 ‎‡2 NTA|326792120
996 ‎‡2 SUDOC|229888208
996 ‎‡2 DNB|13461576X
996 ‎‡2 ISNI|0000000072579788
996 ‎‡2 DNB|127824391
996 ‎‡2 DE633|pe50034797
996 ‎‡2 RERO|A016564767
996 ‎‡2 DNB|121472227X
996 ‎‡2 DNB|1280616016
996 ‎‡2 SUDOC|189850043
996 ‎‡2 SIMACOB|143106403
996 ‎‡2 LC|no2006033981
996 ‎‡2 CAOONL|ncf11717766
996 ‎‡2 DNB|1252757379
996 ‎‡2 DNB|1116587912
996 ‎‡2 SIMACOB|19647331
996 ‎‡2 SZ|1020089555
996 ‎‡2 ISNI|0000000439702659
996 ‎‡2 DNB|132081462X
996 ‎‡2 BAV|495_257142
996 ‎‡2 NUKAT|n 2012065430
996 ‎‡2 DNB|172444233
996 ‎‡2 BAV|495_257146
996 ‎‡2 DE633|pe116663
996 ‎‡2 BAV|495_257144
996 ‎‡2 BAV|495_257145
996 ‎‡2 PLWABN|9810630400605606
996 ‎‡2 RERO|A003961351
996 ‎‡2 DNB|117158437
996 ‎‡2 DNB|1145674917
996 ‎‡2 NTA|070519919
996 ‎‡2 DNB|105118083X
996 ‎‡2 NII|DA04487337
996 ‎‡2 DNB|1046876813
996 ‎‡2 ISNI|0000000066855723
996 ‎‡2 LC|no2009101648
996 ‎‡2 BAV|495_110097
996 ‎‡2 DNB|128566035
996 ‎‡2 PLWABN|9812830482605606
996 ‎‡2 ISNI|0000000018471290
996 ‎‡2 LC|n 86084729
996 ‎‡2 NTA|067671292
996 ‎‡2 ISNI|0000000081150721
996 ‎‡2 NKC|nlk20000084906
996 ‎‡2 DE633|pe198982
996 ‎‡2 DNB|1208533843
996 ‎‡2 DNB|136750117
996 ‎‡2 NUKAT|n 2015146605
996 ‎‡2 ISNI|0000000107643058
996 ‎‡2 SUDOC|192935380
996 ‎‡2 LC|n 82159833
996 ‎‡2 DNB|1031942904
996 ‎‡2 LC|n 2013003554
996 ‎‡2 ISNI|0000000020653130
996 ‎‡2 ISNI|0000000106541703
996 ‎‡2 DNB|1051158966
996 ‎‡2 NTA|306701324
996 ‎‡2 DE633|pe116689
996 ‎‡2 ICCU|CUBV162900
996 ‎‡2 DNB|1043219021
996 ‎‡2 DNB|105549250X
996 ‎‡2 SUDOC|113470746
996 ‎‡2 DNB|137298439
996 ‎‡2 DNB|1309782814
996 ‎‡2 ISNI|0000000072622010
996 ‎‡2 PLWABN|9810666425905606
996 ‎‡2 DNB|1050471814
996 ‎‡2 RERO|A003961340
996 ‎‡2 NUKAT|n 2005102261
996 ‎‡2 DNB|1052875173
996 ‎‡2 DNB|125275101X
996 ‎‡2 DNB|1019511524
996 ‎‡2 ISNI|0000000014746314
996 ‎‡2 DNB|1330632214
996 ‎‡2 NTA|071490728
996 ‎‡2 LC|n 90648869
996 ‎‡2 DNB|1319066666
996 ‎‡2 ISNI|000000010867821X
996 ‎‡2 DNB|116598999
996 ‎‡2 ISNI|0000000507120387
996 ‎‡2 J9U|987007413512305171
996 ‎‡2 ISNI|0000000055571952
996 ‎‡2 BIBSYS|90944300
996 ‎‡2 J9U|987007368444905171
996 ‎‡2 LC|no2010173129
996 ‎‡2 NLR|RU NLR AUTH 7739115
996 ‎‡2 SZ|1079567267
996 ‎‡2 LC|no2016064040
996 ‎‡2 JPG|500011546
996 ‎‡2 NKC|xx0135469
996 ‎‡2 ISNI|0000000025868210
996 ‎‡2 DNB|1011477548
996 ‎‡2 BNF|11928962
996 ‎‡2 DNB|123743540
996 ‎‡2 DNB|1257830279
996 ‎‡2 LC|n 83197682
996 ‎‡2 NTA|132967499
996 ‎‡2 RERO|A017782741
996 ‎‡2 DNB|1274780411
996 ‎‡2 NII|DA12415604
996 ‎‡2 BAV|495_373355
996 ‎‡2 RERO|A003961366
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏